These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32278795)

  • 1. Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease.
    Freeman EE; McMahon DE
    J Am Acad Dermatol; 2020 Jun; 82(6):e231-e232. PubMed ID: 32278795
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving communication about COVID-19 and emerging infectious diseases.
    Jacobsen KH; Vraga EK
    Eur J Clin Invest; 2020 May; 50(5):e13225. PubMed ID: 32294248
    [No Abstract]   [Full Text] [Related]  

  • 3. Considerations for dermatology residency applicants underrepresented in medicine amid the COVID-19 pandemic.
    Jones VA; Clark KA; Patel PM; Cordova A; Tsoukas MM
    J Am Acad Dermatol; 2020 Sep; 83(3):e247-e248. PubMed ID: 32504722
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of early transmission dynamic studies in emerging infectious diseases.
    McBryde E
    Lancet Infect Dis; 2020 May; 20(5):512-513. PubMed ID: 32171058
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatology and COVID-19.
    Shinkai K; Bruckner AL
    JAMA; 2020 Sep; 324(12):1133-1134. PubMed ID: 32960253
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethics and extracorporeal membrane oxygenation during coronavirus disease 2019 outbreak.
    Di Nardo M; Dalle Ore A; Starr J; Cecchetti C; Amodeo A; Testa G
    Perfusion; 2020 Sep; 35(6):562-564. PubMed ID: 32580648
    [No Abstract]   [Full Text] [Related]  

  • 7. [Emerging infections, the great challenge of global health: Covid-19].
    Alpuche-Arand CM
    Salud Publica Mex; 2020; 62(2):123-124. PubMed ID: 32237554
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do.
    Khetan AK
    J Gen Intern Med; 2020 Sep; 35(9):2746-2747. PubMed ID: 32588178
    [No Abstract]   [Full Text] [Related]  

  • 9. The immediate impact of COVID-19 on US dermatology practices.
    Litchman GH; Rigel DS
    J Am Acad Dermatol; 2020 Aug; 83(2):685-686. PubMed ID: 32422226
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic.
    Price KN; Thiede R; Shi VY; Curiel-Lewandrowski C
    J Am Acad Dermatol; 2020 Jun; 82(6):e207-e209. PubMed ID: 32277972
    [No Abstract]   [Full Text] [Related]  

  • 11. Big data and cutaneous manifestations of COVID-19.
    Grant-Kels JM; Sloan B; Kantor J; Elston DM
    J Am Acad Dermatol; 2020 Aug; 83(2):365-366. PubMed ID: 32305440
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing education for dermatology residents during the COVID-19 pandemic.
    Patel P; Guzman AK; McLellan B; Blasiak R
    J Am Acad Dermatol; 2020 Oct; 83(4):e319-e320. PubMed ID: 32682029
    [No Abstract]   [Full Text] [Related]  

  • 13. Modeling infectious disease dynamics.
    Cobey S
    Science; 2020 May; 368(6492):713-714. PubMed ID: 32332062
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on "Dermatology residents and the care of COVID-19 patients".
    Patel B
    J Am Acad Dermatol; 2020 Jul; 83(1):e49. PubMed ID: 32330631
    [No Abstract]   [Full Text] [Related]  

  • 15. Making the world's skin crawl: dermatologic implications of COVID-19.
    Coerdt KM; Khachemoune A
    Cutis; 2020 Jun; 105(6):306-308. PubMed ID: 32716994
    [No Abstract]   [Full Text] [Related]  

  • 16. New SARS-like virus in China triggers alarm.
    Cohen J; Normile D
    Science; 2020 Jan; 367(6475):234-235. PubMed ID: 31949058
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19: another infectious disease emerging at the animal-human interface.
    Murdoch DR; French NP
    N Z Med J; 2020 Feb; 133(1510):12-15. PubMed ID: 32078596
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.
    Nassim D; Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(4):420-421. PubMed ID: 32449619
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating the dermatology communities' public health response to COVID-19.
    Gorrepati PL; Smith GP
    Dermatol Ther; 2020 Jul; 33(4):e13775. PubMed ID: 32506777
    [No Abstract]   [Full Text] [Related]  

  • 20. How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology.
    Jessica Chang TY; Pope JE
    Immunotherapy; 2020 Oct; 12(15):1115-1119. PubMed ID: 32640861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.